Product Information
SERTRALINE HCL 25 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0286 per EA under NDC 65862001101. Its NADAC has been published 419 times since May 30, 2018.
Strength
25 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862001101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077206On Market Since
2/6/2007
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 25 MG TABLET has been published 419 times since May 30, 2018, and over the history we have for it it has declined 55.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0286 per EA |
|---|---|
| All-time high | $0.0786 (Sep 16, 2020) |
| All-time low | $0.0285 (Nov 20, 2024) |
| 52-week high | $0.0336 |
| 52-week low | $0.0286 |
| Median price | $0.0417 |
| Average price | $0.0490 |
| Largest weekly change | +31.1% (Jul 22, 2020) |
| Weeks tracked | 419 |
| Tracking since | May 30, 2018 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 25 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0286 per EA (NDC 65862001101), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 25 MG TABLET has declined 55.2%. It has been tracked across 419 weekly CMS publications since May 30, 2018.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 25 MG TABLET?
Since May 30, 2018, the NADAC for SERTRALINE HCL 25 MG TABLET has ranged from a low of $0.0285 (Nov 20, 2024) to a high of $0.0786 (Sep 16, 2020), with a median of $0.0417 per EA.
Are there cheaper alternatives to SERTRALINE HCL 25 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 25 MG TABLET?
SERTRALINE HCL 25 MG TABLET (NDC 65862001101) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification